Subgroup analysis of rucaparib in platinum-sensitive recurrent ovarian carcinoma: effect of prior chemotherapy regimens in ARIEL3
Authors
Lorusso, DColeman, RL
Oza, AM
Aghajanian, C
Oaknin, A
Dean, A
Colombo, N
Weberpals, JI
Clamp, Andrew R
Scambia, G
Leary, A
Holloway, RW
Gancedo, MA
Fong, PC
Goh, JC
O'Malley, DM
Banerjee, S
Goble, S
Cameron, T
Ledermann, JA
Affiliation
Unit� di Ginecologia Oncologica, Fondazione IRCCS Istituto Nazionale dei Tumori and MITO, Milan, ItalyIssue Date
2018
Metadata
Show full item recordCitation
Lorusso D, Coleman RL, Oza AM, Aghajanian C, Oaknin A, Dean A, et al. 947P Subgroup analysis of rucaparib in platinum-sensitive recurrent ovarian carcinoma: Effect of prior chemotherapy regimens in ARIEL3. Annals of Oncology. 2018;29(suppl_8).Journal
Annals of OncologyDOI
10.1093/annonc/mdy285.155PubMed ID
No PMIDAdditional Links
https://dx.doi.org/10.1093/annonc/mdy285.155Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdy285.155